BN 52021: a platelet activating factor antagonist for preventing post-transplant renal failure. A double-blind, randomized study. The BN 52021 Study Group in Renal Transplantation.
Grino
J M
JM
Department of Nephrology, Hospital de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
D000328:Adult; D000368:Aged; D002102:Cadaver; D004224:Diterpenes; D004311:Double-Blind Method; D005260:Female; D046934:Ginkgolides; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D007783:Lactones / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D051437:Renal Insufficiency / Q000209:etiology / Q000517:prevention & control*
D004224:Diterpenes; D046934:Ginkgolides; D007783:Lactones; D010972:Platelet Activating Factor; C045856:ginkgolide B